To access the full text documents, please follow this link: http://hdl.handle.net/2445/111376
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Nogales, Vanesa |
dc.contributor.author | Reinhold, William C. |
dc.contributor.author | Varma, Sudhir |
dc.contributor.author | Martínez Cardús, Anna |
dc.contributor.author | Moutinho, Cátia |
dc.contributor.author | Moran, Sebastian |
dc.contributor.author | Heyn, Holger |
dc.contributor.author | Sebio, Ana |
dc.contributor.author | Barnadas i Molins, Agustí |
dc.contributor.author | Pommier, Yves |
dc.contributor.author | Esteller, Manel |
dc.date | 2017-05-22T10:09:59Z |
dc.date | 2017-05-22T10:09:59Z |
dc.date | 2016 |
dc.date | 2017-05-22T10:09:59Z |
dc.identifier.citation | 1949-2553 |
dc.identifier.citation | 662705 |
dc.identifier.uri | http://hdl.handle.net/2445/111376 |
dc.format | 14 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Impact Journals |
dc.relation | Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.6413 |
dc.relation | Oncotarget, 2016, vol. 7, num. 3, p. 3084-3097 |
dc.relation | https://doi.org/10.18632/oncotarget.6413 |
dc.rights | cc-by (c) Nogales, Vanesa et al., 2016 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | ADN |
dc.subject | Metilació |
dc.subject | Epigènesi |
dc.subject | Medicaments antineoplàstics |
dc.subject | Cisplatí |
dc.subject | Càncer de pulmó |
dc.subject | Càncer d'ovari |
dc.subject | DNA |
dc.subject | Methylation |
dc.subject | Epigenesis |
dc.subject | Antineoplastic agents |
dc.subject | Cisplatin |
dc.subject | Lung cancer |
dc.subject | Ovarian cancer |
dc.title | Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |